Maison Solutions Inc. MSS
Nov 5, 2026, 12:12 PM EST
- YTD
- -93.65%
- 1 year
- -96.72%
- Market cap
- 879.24K
- Revenue (ttm)
- 73.94M
- Profit margin
- -3.43%
- EPS (ttm)
- -25.68
- Shares out
- 17.45M
- YTD return
- -93.65%
- 1-year return
- -96.72%
- Volume
- 80.71K
- Avg volume
- 3.38M
- Open
- 1.19
- Previous close
- 1.17
- Day's range
- 0.9551 – 1.19
- 52-week range
- 0.941 – 30.50
2Y -46.92 (-97.75%)
Key statistics
- Enterprise value
- 77.60M
- PEG ratio
- 0.00
- Price / sales
- 0.30
- Price / book
- 2.08
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 115.60%
- Free cash flow
- -4.70M
- Total cash
- 588.90K
- Total debt
- 57.96M
- Return on equity
- -45.32%
- Short % of float
- 22.54%
- 50-day average
- 1.01
- 200-day average
- 1.11
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About Maison Solutions Inc.
Maison Solutions Inc., together with its subsidiaries, operates as a specialty grocery retailer in the United States. The company offers perishable products, such as meat, seafood, vegetables, and fruit; non-perishable products, including grocery products comprising cooking utensils, canned foods, Chinese and Asian seasonings and spices, and snacks, as well as liquor, cigarette, lottery, newspaper, reusable bag, non-food, and health products; and general merchandise, beauty care, pharmacy, fuel, and other items and services in its stores. It also offers its products online. The company was formerly known as Maison International, Inc. and changed its name to Maison Solutions Inc. in September 2021. Maison Solutions Inc. was incorporated in 2019 and is headquartered in Monterey Park, California.
- Sector
- Consumer Defensive
- Industry
- Grocery Stores
- Country
- United States
- Website
- maisonsolutionsinc.com
News
Terrestar Solutions joins with Equatys, expanding shared satellite infrastructure for global direct-to-device and advanced MSS connectivity while preserving national sovereignty 
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026 
AST SpaceMobile Advances Service Readiness Ahead of Initial Space-Based Cellular Broadband Coverage in Key Global Markets 
Head to Head Contrast: US Foods (NYSE:USFD) & Maison Solutions (NASDAQ:MSS) 
Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026 
Maison Solutions Receives Non-Compliance Notice From Nasdaq 
Maison Solutions Inc. Receives Additional Nasdaq Notification Regarding Delayed Filing of Quarterly Report on Form 10-Q 
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study 
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy 
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
Your note
Sign in to keep a note on MSS — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 1.19% | 206,911 | 229.67K | Sep 29, 2024 |
| Vanguard Group Inc | 0.60% | 104,800 | 116.33K | Sep 29, 2024 |
| Blackrock Inc. | 0.59% | 102,601 | 113.89K | Sep 29, 2024 |
| HRT Financial LP | 0.26% | 45,423 | 50.42K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.15% | 25,693 | 28.52K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.10% | 17,567 | 19.50K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.44% | 77,000 | 85.47K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.16% | 27,800 | 30.86K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.08% | 13,418 | 14.89K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.05% | 9,145 | 10.15K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.03% | 4,901 | 5.44K | Oct 30, 2024 |